Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/2005
01/19/2005CN1568330A Glycosylphosphatidylinositol containing polypeptides
01/19/2005CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics
01/19/2005CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives
01/19/2005CN1568316A Activator for peroxisome proliferator-responsive receptor delta
01/19/2005CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/19/2005CN1568308A Salts of guanidine derivatives and pharmaceutical preparations consisting thereof
01/19/2005CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines
01/19/2005CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders
01/19/2005CN1568197A Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
01/19/2005CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
01/19/2005CN1568177A Anti-microbial composition comprising a metal ion chelating agent
01/19/2005CN1566335A Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method
01/19/2005CN1566334A Novel reovirus, its antibody and vaccine and use thereof
01/19/2005CN1566158A Recombinant vaccine for prevention and treatment of SARS virus
01/19/2005CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof
01/19/2005CN1566154A Novel hepatocyte growth factor, preparing process and application thereof
01/19/2005CN1566153A Method for separating and extracting saccule peptides from saccules rotundus of rabbits
01/19/2005CN1566152A Immunoreactive peptide Trpi possessing antibacterial action
01/19/2005CN1566144A Functional protein in SARS coronavirus
01/19/2005CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof
01/19/2005CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell
01/19/2005CN1566136A Pasqueflower notoginsenosides and extraction method, medicinal uses and pharmaceutical preparation thereof
01/19/2005CN1566134A Non-structural protein gene of coronavirus and use thereof
01/19/2005CN1566131A Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof
01/19/2005CN1566130A Nucleoside analogue lipid derivative and salt thereof
01/19/2005CN1566129A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
01/19/2005CN1566118A Antiviral activity possessed compound and preparation method thereof
01/19/2005CN1566094A Antiviral activity possessed compound
01/19/2005CN1565631A Usage of fused protein of TNF receptor and globin in acute lung injury treating medicine
01/19/2005CN1565630A Novel pestilence DNA vaccine and its construction and application
01/19/2005CN1565629A Novel pestilence DNA vaccine and its usage
01/19/2005CN1565628A Usage of reovirus genome and its coding protein in the SARS related research
01/19/2005CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
01/19/2005CN1565620A Usage of IL-1 acceptor antagon in the treatment of SARS
01/19/2005CN1565614A Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method
01/19/2005CN1565607A Chinese drug composition for treating viral infection of upper respiratory tract and preparing process thereof
01/19/2005CN1565595A Chinese herbal medicine extracts with antivirus activity and preparing method thereof
01/19/2005CN1565591A Preparation and usage of
01/19/2005CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum
01/19/2005CN1565572A SARS treating medicine
01/19/2005CN1565567A Antivirus medicine and its preparing method
01/19/2005CN1565565A Chinese drugs for treating Hepatitis B and AIDS
01/19/2005CN1565559A Medicine for treating cold and cough
01/19/2005CN1565544A Medicine for treating cold disease
01/19/2005CN1565534A Chinese traditional medicinal combination for treating putrescence of malignant disease
01/19/2005CN1565521A Cold treating pills
01/19/2005CN1565517A Preparing method of nanometer level high purity freeze dried powder of aloe and its preparation
01/19/2005CN1565512A Blood sugar decreasing Chinese herbal medicine for treating SARS patients with diabetes complication
01/19/2005CN1565511A Chinese medicine oral liquid for preventing and treating virulent diarrhea due to the incursion of SARS virus to stomach and intestine
01/19/2005CN1565510A Incense or incense holding box for preventing SARS and other epidemic disease
01/19/2005CN1565490A Chinese herbal medicine prescription for preventing and treating plague of birds and livestock
01/19/2005CN1565475A Pertinent cure, immunity and prevention for atypical pneumonia, all kinds of virus infection of respiratory tract
01/19/2005CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method
01/19/2005CN1565463A Hepatitis B therapeutic medicine
01/19/2005CN1565459A Dermatopathy therapeutic medicine compositions and its preparation method
01/19/2005CN1565457A Beta- lactamase suppressing antibacterial compound drugs
01/19/2005CN1565456A Cefepime compound antibacterial drugs
01/19/2005CN1565455A Antibiotics compositions for curing broad spectrum beta-lactamase bacteria infection
01/19/2005CN1565447A Drug for prevention and cure of bacterial and viral infection , atypical pneumonia
01/19/2005CN1565446A Freeze-drying fluconazole injection and its preparation method
01/19/2005CN1565442A Use of racemoid nor-poon essence A in preparation of AIDS drug
01/19/2005CN1565440A Silymarin Methylglucamine clathrate compound and its preparation method
01/19/2005CN1565431A 3, 4-dihydroxylbenzaldehyde pharmaceutical use
01/19/2005CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method
01/19/2005CN1565422A AIDS drug didanosine granula composition and its preparation method
01/19/2005CN1185254C First hypervariable region antigen of hepatitis C and fusion antigen
01/19/2005CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion
01/19/2005CN1185231C Meadowrueleaf corydalis general alkaloid and its prepn and application
01/19/2005CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs.
01/19/2005CN1185227C Novel compounds
01/19/2005CN1185223C Novel Compounds and methods for synthesis and therapy
01/19/2005CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof
01/19/2005CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines
01/19/2005CN1185012C DNA vaccine pVFS of SARS virus
01/19/2005CN1185011C DNA vaccine pVPS of SARS virus
01/19/2005CN1185005C Medicine for treating inflammation and its preparation method
01/19/2005CN1184986C Spray for preventing and treating cold
01/19/2005CN1184979C Medicine for treating diabetes and phthisis
01/19/2005CN1184972C Composite preparation of sodium para-aminosallicylate and trimethoprim
01/19/2005CN1184968C Antibiotic compositions for treatment of the eye, ear and nose
01/19/2005CN1184964C Use of carbonylamino derivatives against CNS disorders
01/18/2005US6845328 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
01/18/2005US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof
01/18/2005US6844363 Storage stability; drugs; influenza therapy
01/18/2005US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
01/18/2005US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
01/18/2005US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
01/18/2005US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
01/18/2005US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors
01/18/2005US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin
01/18/2005US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
01/18/2005US6844306 Water-soluble, chlorhexidine-containing compositions and use thereof
01/18/2005US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects
01/18/2005US6844179 Protein and DNA thereof
01/18/2005US6844173 Strain of Streptomyces griseus
01/18/2005US6844012 Suppressing cytokine secretion with such as sodium selenite
01/18/2005US6843999 Streptococcal ABC transporter protein
01/18/2005US6843993 Anti-microbial-adhesion fraction derived from vaccinium
01/18/2005US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
01/18/2005US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor